共 75 条
[1]
Hirota SA(2009)Targeting Hypoxia-Inducible Factor-1 (HIF-1) Signaling in Therapeutics: Implications for the Treatment of Inflammatory Bowel Disease Recent Pat Inflamm Allergy Drug Discov 3 1-16
[2]
Beck PL(2008)Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition Gastroenterology 134 145-155
[3]
MacDonald JA(2008)The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis Gastroenterology 134 156-165
[4]
Robinson A(2010)Hydroxylase Inhibition Abrogates TNF-α Induced Intestinal Epithelial Damage by Hypoxia-Inducible Factor-1-Dependent Repression of FADD J Immunol 185 6306-6316
[5]
Keely S(1994)Expression of interleukin-8 gene in inflammatory bowel-disease is related to the histological grade of active inflammation Am J Pathol 144 997-1007
[6]
Karhausen J(1999)Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis J Gastroenterol 34 66-74
[7]
Gerich ME(2004)Siah 2 regulates stability of prolyl-hydroxylases, controls HIF1α abundance, and modulates physiological responses to hypoxia Cell 117 941-952
[8]
Furuta GT(2007)Hypoxia and Gastrointestinal disease J Mol Med 85 1295-1300
[9]
Colgan SP(2006)Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity Proc Natl Acad Sci U S A 103 18154-9
[10]
Cummins EP(2005)The anti-death machinery in IKK/NF-kappaB signaling J Clin Immunol 25 541-50